← Back to Clinical Trials
Recruiting NCT05692973

NCT05692973 The Role of Knowledge Retrieval in Inference-making

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05692973
Status Recruiting
Phase
Sponsor William Jewell College
Condition Reading Disability
Study Type INTERVENTIONAL
Enrollment 316 participants
Start Date 2023-05-31
Primary Completion 2026-08-31

Eligibility & Interventions

Sex All sexes
Min Age 8 Years
Max Age 14 Years
Study Type INTERVENTIONAL
Interventions
Role of Knowledge RetrievalInference Intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 316 participants in total. It began in 2023-05-31 with a primary completion date of 2026-08-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This project will (a) examine the relationship between knowledge retrieval and inferencing; (b) determine the effectiveness of an intervention that improves knowledge retrieval and inferencing among struggling readers; and (c) expand research opportunities for undergraduates. The research design uses 316 struggling readers in grades 4-6 of diverse backgrounds. The effects of knowledge retrieval (accuracy and speed) on inferencing will be modeled without dichotomizing the distribution. Linear mixed effect models will be fit to determine whether reader characteristics make unique contributions to inferencing across the posttest and follow-up data collection time points. First, several structural models will be considered as students may be nested in teachers, schools, and tutors. Unconditional models will estimate the intraclass correlation for each level of the study design. If significant interclass correlations emerge, multilevel models will be fit to evaluate the effectiveness of the intervention while controlling for covariates such as pre-test performance on inference-related measures and child-attributes such as English learner status. The primary analysis plan assumes an intent-to-treat model in which the efficacy of two intact conditions will be tested. Effect sizes will be estimated to report the magnitude of difference between the two conditions. Expected outcomes include (a) the identification of a method that effectively facilitates knowledge retrieval and the application of relevant knowledge to form inferences among elementary struggling readers from diverse backgrounds; (b) the validation of an intervention that teaches struggling readers how to activate, retrieve, and interweave relevant knowledge with information in the text and accurately form inferences while reading that can be broadly implemented in general education classrooms; and (c) expansion of undergraduate research opportunities, particularly among students from diverse backgrounds who have been historically underserved.

Eligibility Criteria

Inclusion Criteria: * performance below a a standard score of 93 on the Test of Silent Reading Efficiency Exclusion Criteria: * clinical diagnosis of a significant cognitive impairment * clinical diagnosis of a significant behavioral disability

Contact & Investigator

Central Contact

Andrea Meloan, BS

✉ meloana@william.jewell.edu

📞 816-415-7831

Principal Investigator

Amy E Barth, Ph.D

PRINCIPAL INVESTIGATOR

William Jewell College

Frequently Asked Questions

Who can join the NCT05692973 clinical trial?

This trial is open to participants of all sexes, aged 8 Years or older, up to 14 Years, studying Reading Disability. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05692973 currently recruiting?

Yes, NCT05692973 is actively recruiting participants. Contact the research team at meloana@william.jewell.edu for enrollment information.

Where is the NCT05692973 trial being conducted?

This trial is being conducted at Excelsior Springs, United States.

Who is sponsoring the NCT05692973 clinical trial?

NCT05692973 is sponsored by William Jewell College. The principal investigator is Amy E Barth, Ph.D at William Jewell College. The trial plans to enroll 316 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology